Titre : Dystonie

Dystonie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Program Evaluation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dystonie : Questions médicales les plus fréquentes", "headline": "Dystonie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dystonie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-28", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dystonie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dyskinésies", "url": "https://questionsmedicales.fr/mesh/D020820", "about": { "@type": "MedicalCondition", "name": "Dyskinésies", "code": { "@type": "MedicalCode", "code": "D020820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.350" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Torticolis", "alternateName": "Torticollis", "url": "https://questionsmedicales.fr/mesh/D014103", "about": { "@type": "MedicalCondition", "name": "Torticolis", "code": { "@type": "MedicalCode", "code": "D014103", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.350.300.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Dystonie", "alternateName": "Dystonia", "code": { "@type": "MedicalCode", "code": "D004421", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "H A Jinnah", "url": "https://questionsmedicales.fr/author/H%20A%20Jinnah", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Alfredo Berardelli", "url": "https://questionsmedicales.fr/author/Alfredo%20Berardelli", "affiliation": { "@type": "Organization", "name": "From the Departments of Biomedical Engineering (A.G.S., S.B.B.) and Neurology (A.G.S.), Case Western University School of Medicine; Neurological Institute (A.G.S.), University Hospitals Cleveland; Neurology Service (A.G.S.), Louis Stokes Cleveland VA Medical Center, OH; Department of Neurology (L.S., G.K.-B., A.F., S. Factor, H.A.J.), Human Genetics (H.A.J.), and Pediatrics (H.A.J.), Emory University School of Medicine, Atlanta, GA; Institute of Neurogenetics (C.K., J.J., S.L., N.B., A.M., T.B.), University of Lübeck, Germany; Department of Neurology (M.V., E.R., C.B.), Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (J.J.), Baylor College of Medicine, Houston, TX; Neurology and Neurosurgery (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Neurology (N.P.), Henry Ford Health System, West Bloomfield, MI; Department of Psychiatry and Neurology (L.M.), Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (C.C.), Rush University Medical Center, Chicago, IL; Department of Neurology (R.L.B.), University of Rochester, NY; Department of Neurology (B.D.B.), University of Colorado School of Medicine, Aurora; Department of Neurology (I.M., A.W.S.), Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville; Department of Neurology (S.G.R.), University of Maryland School of Medicine, Baltimore; University of Tennessee Health Science Center (M.S.L.), Memphis; Department of Neurosciences (A.B.), Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome; IRCCS Neuromed (G.F.), Pozzilli, Italy; The University of Alabama at Birmingham (N.S.); Methodist Neurological Institute (W.O.), Houston, TX; Department of Neurology (S.P.R.), University of New Mexico Health Sciences Center, Albuquerque; Department of Neurology (R.S.-P.), Mount Sinai Beth Israel, New York, NY; Lou Ruvo Center for Brain Health (Z.M.), Cleveland Clinic, Las Vegas, NV; Booth Gardner Parkinson's Care Center (P.A.), Kirkland, WA; Mayo Clinic (C.A.), Scottsdale, AZ; Andre Barbeau Movement Disorders Unit (S.C.), Montreal University Hospital Center (CHUM); Movement Disorder Clinic (S.H.F.), Toronto Western Hospital, Division of Neurology University of Toronto, Canada; UC Davis School of Medicine (A.B.), Sacramento; The Parkinson's and Movement Disorder Institute (D.T.), Orange Coast Memorial Medical Center, Fountain Valley, CA; Department of Medicine (O.S.), Medical Genetics, and Pediatrics, University of Alberta, Canada; Department of Neurology (S. Frank), Beth Israel Deaconess Medical Center, Boston, MA; and Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy (J.P.), Washington University School of Medicine, St Louis, MO." } }, { "@type": "Person", "name": "Michael Zech", "url": "https://questionsmedicales.fr/author/Michael%20Zech", "affiliation": { "@type": "Organization", "name": "Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany. Electronic address: michael.zech@mri.tum.de." } }, { "@type": "Person", "name": "Gamze Kilic-Berkmen", "url": "https://questionsmedicales.fr/author/Gamze%20Kilic-Berkmen", "affiliation": { "@type": "Organization", "name": "From the Departments of Biomedical Engineering (A.G.S., S.B.B.) and Neurology (A.G.S.), Case Western University School of Medicine; Neurological Institute (A.G.S.), University Hospitals Cleveland; Neurology Service (A.G.S.), Louis Stokes Cleveland VA Medical Center, OH; Department of Neurology (L.S., G.K.-B., A.F., S. Factor, H.A.J.), Human Genetics (H.A.J.), and Pediatrics (H.A.J.), Emory University School of Medicine, Atlanta, GA; Institute of Neurogenetics (C.K., J.J., S.L., N.B., A.M., T.B.), University of Lübeck, Germany; Department of Neurology (M.V., E.R., C.B.), Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (J.J.), Baylor College of Medicine, Houston, TX; Neurology and Neurosurgery (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Neurology (N.P.), Henry Ford Health System, West Bloomfield, MI; Department of Psychiatry and Neurology (L.M.), Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (C.C.), Rush University Medical Center, Chicago, IL; Department of Neurology (R.L.B.), University of Rochester, NY; Department of Neurology (B.D.B.), University of Colorado School of Medicine, Aurora; Department of Neurology (I.M., A.W.S.), Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville; Department of Neurology (S.G.R.), University of Maryland School of Medicine, Baltimore; University of Tennessee Health Science Center (M.S.L.), Memphis; Department of Neurosciences (A.B.), Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome; IRCCS Neuromed (G.F.), Pozzilli, Italy; The University of Alabama at Birmingham (N.S.); Methodist Neurological Institute (W.O.), Houston, TX; Department of Neurology (S.P.R.), University of New Mexico Health Sciences Center, Albuquerque; Department of Neurology (R.S.-P.), Mount Sinai Beth Israel, New York, NY; Lou Ruvo Center for Brain Health (Z.M.), Cleveland Clinic, Las Vegas, NV; Booth Gardner Parkinson's Care Center (P.A.), Kirkland, WA; Mayo Clinic (C.A.), Scottsdale, AZ; Andre Barbeau Movement Disorders Unit (S.C.), Montreal University Hospital Center (CHUM); Movement Disorder Clinic (S.H.F.), Toronto Western Hospital, Division of Neurology University of Toronto, Canada; UC Davis School of Medicine (A.B.), Sacramento; The Parkinson's and Movement Disorder Institute (D.T.), Orange Coast Memorial Medical Center, Fountain Valley, CA; Department of Medicine (O.S.), Medical Genetics, and Pediatrics, University of Alberta, Canada; Department of Neurology (S. Frank), Beth Israel Deaconess Medical Center, Boston, MA; and Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy (J.P.), Washington University School of Medicine, St Louis, MO." } }, { "@type": "Person", "name": "Roberto Erro", "url": "https://questionsmedicales.fr/author/Roberto%20Erro", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", University of Salerno, Baronissi (SA), Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The effectiveness of simulation-based learning (SBL) on students' knowledge and skills in nursing programs: a systematic review.", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39375684", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-06080-z" } }, { "@type": "ScholarlyArticle", "name": "Implementing a national programme of pathogen genomics for public health: the Australian Pathogen Genomics Program (AusPathoGen).", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39389079", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.lanmic.2024.100969" } }, { "@type": "ScholarlyArticle", "name": "Promoting sustained access to cognitive behavioral therapy for insomnia in Australia: a system-level implementation program.", "datePublished": "2024-10-04", "url": "https://questionsmedicales.fr/article/39364910", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5664/jcsm.11374" } }, { "@type": "ScholarlyArticle", "name": "Effectiveness of Colonoscopy in Reducing Incidence of Late-stage Colorectal Cancer Within an Opportunistic Screening Program.", "datePublished": "2024-10-01", "url": "https://questionsmedicales.fr/article/39353877", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLE.0000000000001326" } }, { "@type": "ScholarlyArticle", "name": "Community Paramedicine Program in Social Housing and Health Service Utilization: A Cluster Randomized Clinical Trial.", "datePublished": "2024-10-01", "url": "https://questionsmedicales.fr/article/39466243", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.41288" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Dyskinésies", "item": "https://questionsmedicales.fr/mesh/D020820" }, { "@type": "ListItem", "position": 6, "name": "Dystonie", "item": "https://questionsmedicales.fr/mesh/D004421" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dystonie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dystonie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dystonie", "description": "Comment diagnostique-t-on la dystonie ?\nQuels tests sont utilisés pour la dystonie ?\nLa dystonie est-elle héréditaire ?\nQuels spécialistes consultent pour la dystonie ?\nY a-t-il des critères spécifiques pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Program+Evaluation&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dystonie", "description": "Quels sont les symptômes courants de la dystonie ?\nLa dystonie affecte-t-elle la parole ?\nLes symptômes de la dystonie sont-ils constants ?\nLa dystonie peut-elle causer de la douleur ?\nY a-t-il des types spécifiques de dystonie ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Program+Evaluation&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dystonie", "description": "Peut-on prévenir la dystonie ?\nLe stress influence-t-il la dystonie ?\nLes exercices physiques aident-ils à prévenir la dystonie ?\nY a-t-il des facteurs environnementaux à éviter ?\nL'éducation sur la dystonie est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Program+Evaluation&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dystonie", "description": "Quels traitements sont disponibles pour la dystonie ?\nLes médicaments sont-ils efficaces pour la dystonie ?\nLa toxine botulique est-elle utilisée pour la dystonie ?\nLa thérapie physique aide-t-elle la dystonie ?\nQuand la chirurgie est-elle envisagée pour la dystonie ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Program+Evaluation&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dystonie", "description": "Quelles complications peuvent survenir avec la dystonie ?\nLa dystonie peut-elle affecter la qualité de vie ?\nY a-t-il des risques psychologiques associés à la dystonie ?\nLa dystonie peut-elle entraîner des blessures ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Program+Evaluation&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dystonie", "description": "Quels sont les facteurs de risque de la dystonie ?\nL'âge influence-t-il le risque de dystonie ?\nLes femmes sont-elles plus à risque de dystonie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes médicaments peuvent-ils être un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D004421?mesh_terms=Program+Evaluation&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la dystonie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'historique médical, parfois complété par des tests d'imagerie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la dystonie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des IRM cérébrales et des électromyogrammes peuvent être réalisés pour évaluer la fonction musculaire." } }, { "@type": "Question", "name": "La dystonie est-elle héréditaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Certaines formes de dystonie peuvent être héréditaires, nécessitant une évaluation génétique." } }, { "@type": "Question", "name": "Quels spécialistes consultent pour la dystonie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les neurologues sont les principaux spécialistes impliqués dans le diagnostic de la dystonie." } }, { "@type": "Question", "name": "Y a-t-il des critères spécifiques pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des critères cliniques spécifiques, comme le type de mouvements involontaires, sont utilisés." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la dystonie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des contractions musculaires, des mouvements anormaux et des postures tordues." } }, { "@type": "Question", "name": "La dystonie affecte-t-elle la parole ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dystonie peut affecter la parole, entraînant des difficultés d'élocution." } }, { "@type": "Question", "name": "Les symptômes de la dystonie sont-ils constants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent varier en intensité et peuvent être exacerbés par le stress." } }, { "@type": "Question", "name": "La dystonie peut-elle causer de la douleur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les contractions musculaires peuvent entraîner des douleurs et de l'inconfort." } }, { "@type": "Question", "name": "Y a-t-il des types spécifiques de dystonie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe plusieurs types, comme la dystonie focale et la dystonie généralisée." } }, { "@type": "Question", "name": "Peut-on prévenir la dystonie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider." } }, { "@type": "Question", "name": "Le stress influence-t-il la dystonie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes de la dystonie, donc la gestion du stress est importante." } }, { "@type": "Question", "name": "Les exercices physiques aident-ils à prévenir la dystonie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des exercices réguliers peuvent améliorer la condition physique et potentiellement réduire les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à éviter ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les toxines environnementales et les traumatismes peut réduire le risque de dystonie." } }, { "@type": "Question", "name": "L'éducation sur la dystonie est-elle utile ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une meilleure compréhension de la maladie peut aider les patients à gérer leurs symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la dystonie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des thérapies physiques et parfois la chirurgie." } }, { "@type": "Question", "name": "Les médicaments sont-ils efficaces pour la dystonie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme les anticholinergiques peuvent réduire les symptômes chez certains patients." } }, { "@type": "Question", "name": "La toxine botulique est-elle utilisée pour la dystonie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les injections de toxine botulique peuvent aider à réduire les spasmes musculaires." } }, { "@type": "Question", "name": "La thérapie physique aide-t-elle la dystonie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie physique peut améliorer la mobilité et réduire la douleur associée." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle envisagée pour la dystonie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée lorsque les traitements médicamenteux échouent à soulager les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la dystonie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des douleurs chroniques, des troubles de la posture et des difficultés fonctionnelles." } }, { "@type": "Question", "name": "La dystonie peut-elle affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dystonie peut significativement affecter la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Y a-t-il des risques psychologiques associés à la dystonie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent éprouver de l'anxiété et de la dépression en raison de leur condition." } }, { "@type": "Question", "name": "La dystonie peut-elle entraîner des blessures ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les mouvements involontaires peuvent causer des chutes et des blessures accidentelles." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées ou améliorées avec un traitement approprié." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la dystonie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des traumatismes crâniens et certaines maladies neurologiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de dystonie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la dystonie peut survenir à tout âge, mais certains types apparaissent plus souvent chez les jeunes adultes." } }, { "@type": "Question", "name": "Les femmes sont-elles plus à risque de dystonie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que les femmes peuvent être plus susceptibles de développer certains types de dystonie." } }, { "@type": "Question", "name": "Les maladies neurologiques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme la maladie de Parkinson peuvent augmenter le risque de dystonie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils être un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments, comme les antipsychotiques, peuvent induire des symptômes de dystonie." } } ] } ] }

Sources (10000 au total)

The effectiveness of simulation-based learning (SBL) on students' knowledge and skills in nursing programs: a systematic review.

Simulation-Based Learning (SBL) serves as a valuable pedagogical approach in nursing education, encompassing varying levels of fidelity. While previous reviews have highlighted the potential effective... A comprehensive search of electronic databases, including CINAHL, PubMed, Embase, Scopus, and Eric, was conducted from 2017 to 2023 to identify relevant studies. The Joanna Briggs critical appraisal t... The cumulative sample size of participants across the included studies was 3,670. Most of the studies focused on the impact of SBL on life-saving skills like cardiopulmonary resuscitation (CPR) or oth... This systematic review supports the use of SBL as a potent teaching strategy within nursing education and highlights the importance of the ongoing evaluation and refinement of this approach. While cur...

Promoting sustained access to cognitive behavioral therapy for insomnia in Australia: a system-level implementation program.

Insomnia is a highly prevalent and debilitating disorder. Cognitive behavioral therapy for insomnia (CBTi) is the recommended 'fist line' treatment, but is accessed by a minority of people with insomn... From 2019 to 2023, we conducted a program of work to promote sustained change in access to CBTi in Australia. Three distinct phases included 1) Scoping and mapping barriers to CBTi access, 2) Analysis... We identified barriers to CBTi access from the perspectives of people with insomnia, primary care clinicians, and the health system. A stakeholder advisory committee was convened to co-design change g... This implementation program made significant progress toward improving access to CBTi in Australia. Ongoing work is required to continue this program, as long-term system-level change requires signifi...

Effectiveness of Colonoscopy in Reducing Incidence of Late-stage Colorectal Cancer Within an Opportunistic Screening Program.

The effectiveness of colonoscopy in preventing colorectal cancer (CRC) within opportunistic screening programs has not been clearly established. The aim of this study was to analyze the effectiveness ... Subjects who received a diagnosis of CRC (CG) between the ages of 50 and 90 years were included and matched by age and gender in a 1:5 ratio with patients without CRC diagnosis (COG) during the period... Of the 134 patients in CG, 19 (14.18%) had a colonoscopy in the preceding 5 years compared with 258 out of 670 (38.51%) in COG (AOR, 0.24; 95% CI: 0.14-0.41). Any colonoscopy was strongly associated w... In the setting of an opportunistic screening program, exposure to any colonoscopy significantly reduced left-sided CRC incidence; however, only high-quality colonoscopy was associated with a lower inc...

Community Paramedicine Program in Social Housing and Health Service Utilization: A Cluster Randomized Clinical Trial.

Community Paramedicine at Clinic (CP@clinic) is a chronic disease prevention program that decreases 911 calls for emergency medical services, but its wider system effects are unknown.... To evaluate the effects of CP@clinic vs usual care on individual-level health service utilization outcomes.... This open-label, pragmatic cluster randomized clinical trial evaluated all residents 55 years or older in 30 social housing buildings in Ontario, Canada, that had (1) a unique postal code, (2) at leas... CP@clinic was a health promotion and disease prevention program led by specially trained community paramedics who held weekly drop-in sessions in social housing buildings. These paramedics conducted 1... Individual-level health service utilization was measured from administrative health data, with ED visits via ambulance as the primary outcome; secondary outcomes included ED visits for any reason, pri... The 30 social housing buildings had 3695 residents (1846 control and 1849 intervention participants; mean [SD] age, 72.8 [9.1] years; 2400 [65.0%] female). Intention-to-treat analysis found no signifi... In this cluster randomized clinical trial of CP@clinic, the intervention did not affect the rate of ED visits by ambulance; however, there were increased primary care visits and connections to home ca... ClinicalTrials.gov Identifier: NCT02152891....

Temporal Dynamics of Hepatitis B Infection and Relation of Childhood Vaccination Program in Türkiye: A Longitudinal Study.

Hepatitis B is a significant infectious disease on a global scale. The implementation of vaccination programs and other preventive measures (e.g., serologic screening of blood donors) leads to lower r... The study analyzed open datasets (the Global Burden of Disease and Our World in Data) using descriptive and joinpoint regression analysis to uncover substantial declines in hepatitis B rates from 1990... The average annual percentage change (AAPC) for incidence rates was -1.81 in Türkiye and -1.481 in the global cohort. For prevalence, the AAPC was -2.5244 in Türkiye and -1.4104 globally.... The vaccination rates increased over time and remained at 95% since 2009, suggesting that vaccination efforts effectively reduced the risk of hepatitis B infection among children. This study provided ...

Impact of a diabetic retinal exam screening program on quality measure gaps at a family medicine practice.

Diabetic retinopathy is a common complication in people with diabetes and annual screening is recommended by the American Diabetes Association. This annual exam is also a HEDIS quality measure. Barrie... The objective of this study is to describe the impact of a diabetic retinal exam screening program at a rural family medicine center on the number of quality measure gaps resolved.... This study occurred at a rural family medicine center in southwestern Pennsylvania with a medically underserved patient population. A pharmacist at the site holds boards certifications in Advanced Dia... A regional Medicaid plan provided a list of patients with a quality measure gap for an annual DRE and loaned a RetinaVue 700 Imager to take retinal photos. After screening eligible patients via phone,... The rate of quality measure gaps closed and satisfaction survey results are reported using descriptive statistics.... A total of 61 patients were included in the analysis. This program closed quality measure gaps for 11 (18.0%) patients who were able to receive an in-office eye exam.... This pilot project shows that offering in-office diabetic retinal exams may be an effective strategy to close quality measure gaps and provide access to screening among a medically underserved populat...

Outcomes of a Comprehensive Mobile Vaping Cessation Program in Adults Who Vape Daily: Cohort Study.

In the United States, e-cigarettes, or vapes, are the second most-commonly used tobacco product. Despite abundant smartphone app-based cigarette cessation programs, there are few such programs for vap... This exploratory, prospective open-label, single-arm, remote, initial cohort study of the Pivot vaping cessation program assessed enrollment and questionnaire completion rates, participant engagement ... U.S. adults aged ≥ 21 years who vape daily, report ≥ 5 vape sessions per day, and plan to quit vaping in the next 6 months were recruited online. Participants completed an online screening form, scree... Seventy-three participants completed onboarding (intention-to-treat [ITT] sample); 68/73 (93%) completed the 12- and 26-week questionnaires (completer samples). On average, participants were active in... In this first evaluation of Pivot in adult daily vapers, questionnaire completion rates were >90%, average program engagement duration was approximately 14 weeks and most participants reported increas... ClinicalTrials.gov NCT05642598; https://clinicaltrials.gov/study/NCT05642598....